I'm a pharmacist too... Used to work in retail for Osco, Brooks and Target. Now I'm in the field of nuclear pharmacy, but I still follow closely the world of traditional meds. I had the opportunity of buying into Mylan for the first time a few weeks ago at 7.25, followed by another purchase at 6.25. The opportunity for investing is great here. I believe we're still significantly undervalued. I'll be holding for the very long run given the huge potential of this company.